Displaying 131 - 135 of 180
Thu 20 March 2014
Today the Cancer Drugs Fund Panel (CDF) announced its decision to approve Abraxane® (Paclitaxel Albumin), for inclusion on the list of cancer drugs that are made available on the NHS prior to an assessment by the National Institute for Care and Health Excellence (NICE).Read More about 'Abraxane added to Cancer Drugs Fund list!'
Tue 18 March 2014
New report highlights that more needs to be done to improve poor pancreatic cancer survival ratesRead More about 'First ever European Index of pancreatic cancer care results'
Tue 25 February 2014
Pancreatic Cancer UK launches "two more months" campaign ahead of crucial decision by The Cancer Drugs Fund.Read More about 'Two More Months'
Fri 21 February 2014
The Health Consumer Powerhouse (HCP) are soon to launch the European Pancreatic Cancer Index (ECPI) inspired by our Study for Survival report.Read More about 'Europe-wide pancreatic cancer index coming soon'
Wed 29 January 2014
In a bid to achieve our aim of ensuring everyone diagnosed with pancreatic cancer in the UK has access to information about our services, we have launched a Newly Diagnosed pack for patients, piloting it's use in hospitals throughout the UK.Read More about 'Introducing our Newly Diagnosed patient pack'